293 related articles for article (PubMed ID: 30134546)
21. Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.
Riou R; Bressollette-Bodin C; Boutoille D; Gagne K; Rodallec A; Lefebvre M; Raffi F; Senitzer D; Imbert-Marcille BM; Retière C
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031361
[TBL] [Abstract][Full Text] [Related]
22. Rho-Associated Coiled-Coil Kinase 1 Translocates to the Nucleus and Inhibits Human Cytomegalovirus Propagation.
Eliyahu E; Tirosh O; Dobesova M; Nachshon A; Schwartz M; Stern-Ginossar N
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292242
[TBL] [Abstract][Full Text] [Related]
23. Quantitative temporal viromics: an approach to investigate host-pathogen interaction.
Weekes MP; Tomasec P; Huttlin EL; Fielding CA; Nusinow D; Stanton RJ; Wang ECY; Aicheler R; Murrell I; Wilkinson GWG; Lehner PJ; Gygi SP
Cell; 2014 Jun; 157(6):1460-1472. PubMed ID: 24906157
[TBL] [Abstract][Full Text] [Related]
24. Evidence for positive selection in the extracellular domain of human cytomegalovirus encoded G protein-coupled receptor US28.
Gong X; Padhi A
J Med Virol; 2011 Jul; 83(7):1255-61. PubMed ID: 21520142
[TBL] [Abstract][Full Text] [Related]
25. Human cytomegalovirus targets different subsets of antigen-presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflammation and autoimmunity.
Varani S; Frascaroli G; Landini MP; Söderberg-Nauclér C
Rev Med Virol; 2009 May; 19(3):131-45. PubMed ID: 19367559
[TBL] [Abstract][Full Text] [Related]
26. Induction and evasion of the type I interferon response by cytomegaloviruses.
DeFilippis VR
Adv Exp Med Biol; 2007; 598():309-24. PubMed ID: 17892221
[TBL] [Abstract][Full Text] [Related]
27. MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance.
Benz C; Hengel H
Virus Genes; 2000; 21(1-2):39-47. PubMed ID: 11022788
[TBL] [Abstract][Full Text] [Related]
28. High-Definition Analysis of Host Protein Stability during Human Cytomegalovirus Infection Reveals Antiviral Factors and Viral Evasion Mechanisms.
Nightingale K; Lin KM; Ravenhill BJ; Davies C; Nobre L; Fielding CA; Ruckova E; Fletcher-Etherington A; Soday L; Nichols H; Sugrue D; Wang ECY; Moreno P; Umrania Y; Huttlin EL; Antrobus R; Davison AJ; Wilkinson GWG; Stanton RJ; Tomasec P; Weekes MP
Cell Host Microbe; 2018 Sep; 24(3):447-460.e11. PubMed ID: 30122656
[TBL] [Abstract][Full Text] [Related]
29. Human cytomegalovirus UL7, a homologue of the SLAM-family receptor CD229, impairs cytokine production.
Engel P; Pérez-Carmona N; Albà MM; Robertson K; Ghazal P; Angulo A
Immunol Cell Biol; 2011 Oct; 89(7):753-66. PubMed ID: 21670740
[TBL] [Abstract][Full Text] [Related]
30. Immune evasion by human cytomegalovirus: lessons in immunology and cell biology.
Loenen WA; Bruggeman CA; Wiertz EJ
Semin Immunol; 2001 Feb; 13(1):41-9. PubMed ID: 11289798
[TBL] [Abstract][Full Text] [Related]
31. Human cytomegalovirus persists in its host and attacks and avoids elimination by the immune system.
Soderberg-Naucler C
Crit Rev Immunol; 2006; 26(3):231-64. PubMed ID: 16928188
[TBL] [Abstract][Full Text] [Related]
32. The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection.
Scalzo AA; Corbett AJ; Rawlinson WD; Scott GM; Degli-Esposti MA
Immunol Cell Biol; 2007 Jan; 85(1):46-54. PubMed ID: 17146464
[TBL] [Abstract][Full Text] [Related]
33. Viral immunomodulatory proteins: usurping host genes as a survival strategy.
Engel P; Angulo A
Adv Exp Med Biol; 2012; 738():256-76. PubMed ID: 22399384
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of human cytomegalovirus infection with a focus on epidermal growth factor receptor interactions.
Falcão ASC; da Costa Vasconcelos PF; Lobato da Silva DF; Viana Pinheiro JJ; Falcão LFM; Quaresma JAS
Rev Med Virol; 2017 Nov; 27(6):. PubMed ID: 29024283
[TBL] [Abstract][Full Text] [Related]
35. The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity.
Biolatti M; Dell'Oste V; Scutera S; Gugliesi F; Griffante G; De Andrea M; Musso T; Landolfo S
Viruses; 2018 Oct; 10(10):. PubMed ID: 30332797
[TBL] [Abstract][Full Text] [Related]
36. Unravelling the interaction of human cytomegalovirus with dendritic cells by using SuperSAGE.
Raftery MJ; Möncke-Buchner E; Matsumura H; Giese T; Winkelmann A; Reuter M; Terauchi R; Schönrich G; Krüger DH
J Gen Virol; 2009 Sep; 90(Pt 9):2221-33. PubMed ID: 19439557
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of HCMV-specific immune responses: Parallels between CD8(+) T cells, CD4(+) T cells, and NK cells.
Vieira Braga FA; Hertoghs KM; van Lier RA; van Gisbergen KP
Eur J Immunol; 2015 Sep; 45(9):2433-45. PubMed ID: 26228786
[TBL] [Abstract][Full Text] [Related]
38. Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses.
Wu Z; Sinzger C; Reichel JJ; Just M; Mertens T
J Virol; 2015 Mar; 89(5):2906-17. PubMed ID: 25540381
[TBL] [Abstract][Full Text] [Related]
39. APOBEC3A Is Upregulated by Human Cytomegalovirus (HCMV) in the Maternal-Fetal Interface, Acting as an Innate Anti-HCMV Effector.
Weisblum Y; Oiknine-Djian E; Zakay-Rones Z; Vorontsov O; Haimov-Kochman R; Nevo Y; Stockheim D; Yagel S; Panet A; Wolf DG
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956761
[TBL] [Abstract][Full Text] [Related]
40. Restoring immune defenses via lymphotoxin signaling: lessons from cytomegalovirus.
Banks TA; Rickert S; Ware CF
Immunol Res; 2006; 34(3):243-54. PubMed ID: 16891674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
